
Semler Scientific (SMLR) Stock Forecast & Price Target
Semler Scientific (SMLR) Analyst Ratings
Bulls say
Semler Scientific, Inc. is well-positioned for growth due to its proprietary vascular-testing product, QuantaFlo, which enhances the efficiency of healthcare providers in managing chronic diseases. The company’s strategic focus on healthcare technology solutions generates substantial cash flows, allowing it to invest in alternative assets like bitcoin, which adds another layer of financial resilience. Furthermore, the anticipated closing of a deal with Strive presents a promising opportunity, as the current SMLR discount to the implied deal value may indicate significant upside potential in the company's stock valuation.
Bears say
Semler Scientific faces a negative outlook primarily due to significant market skepticism regarding its valuation, exacerbated by the volatile nature of bitcoin, which impacts its treasury reserve strategy. The company's financial stability is further questioned as the implied value for Semler may diminish if Strive’s share price declines ahead of a key vote, potentially leading to renegotiation pressures. Additionally, the deal’s economics are closely linked to bitcoin's performance, which has been unfavorable, indicating that the market has not fully recognized or valued the implications of Strive’s strategy.
This aggregate rating is based on analysts' research of Semler Scientific and is not a guaranteed prediction by Public.com or investment advice.
Semler Scientific (SMLR) Analyst Forecast & Price Prediction
Start investing in Semler Scientific (SMLR)
Order type
Buy in
Order amount
Est. shares
0 shares